Tweets by @BlueprintLSG

Newsroom

Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)
Thursday October 06, 2022

‘Take Opportunities on Days Like Today’: Mary Callahan Erdoes Says Now Could Be the Best Time to Invest. Here Are 3 Stocks to Consider
Thursday October 06, 2022

New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life
Thursday October 06, 2022

German COVID vaccine developer BioNTech signs research deal with Australia
Thursday October 06, 2022